Natural killer T cells regulate the homing of chemokine CXC receptor 3-positive regulatory T cells to the liver in mice #
Authors:
Open Access
- 27 March 2009
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 49 (4) , 1267-1276
Abstract
Natural killer T (NKT) cells and regulatory T cells (Tregs) are both found within the liver and are known to exhibit immune regulatory functions. Hepatic NKT cells are activated early during inflammatory responses and release cytokines, including interferon gamma (IFN-γ), which we speculated could regulate Treg recruitment to the liver. To examine this, we treated C57BL/6 mice with a specific NKT cell activating ligand α galactosyl-C18-ceramide (αGal-C18-Cer) and examined the hepatic recruitment of Tregs. We found a time-dependant increase in the hepatic recruitment of Tregs after NKT cell activation, which was absent in NKT cell–deficient mice. Most recruited Tregs expressed interleukin (IL) 10, and to a lesser extent transforming growth factor beta (TGF-β). Because IFN-γ induces the production of chemokine (C-X-C motif) ligand 10 (CXCL10), and Tregs can express the cognate receptor for CXCL10 (that is, CXCR3), we considered that CXCL10 might mediate the hepatic recruitment of Tregs after NKT cell activation. Hepatic CXCL10 levels were markedly increased after αGal-C18-Cer administration in wild-type but not in NKT cell–deficient mice. Moreover, approximately 50% of Tregs recruited to the liver after αGal-C18-Cer administration expressed CXCR3 and CXCR3+ Treg recruitment into the liver was significantly inhibited in IFN-γ KO mice, and after CXCL10 neutralization. In addition, prevention of CXCR3+ Treg recruitment into the liver enhanced inflammatory effector cell recruitment into the liver after αGal-C18-Cer treatment. Conclusion: These results show that activated NKT cells can induce the hepatic recruitment of Tregs through a cytokine-to-chemokine pathway, which could be relevant in the development of chemokine blocking or NKT cell activating strategies to treat liver diseases. (Hepatology 2009.)Keywords
This publication has 44 references indexed in Scilit:
- Therapeutic effect of CXCR3-expressing regulatory T cells on liver, lung and intestinal damages in a murine acute GVHD modelGene Therapy, 2007
- CCR5 Deficiency Drives Enhanced Natural Killer Cell Trafficking to and Activation within the Liver in Murine T Cell-Mediated HepatitisThe American Journal of Pathology, 2007
- Tregs and rethinking cancer immunotherapyJournal of Clinical Investigation, 2007
- Natural regulatory T cells: mechanisms of suppressionTrends in Molecular Medicine, 2007
- The role of chemokines as inflammatory mediators in chronic hepatitis C virus infectionJournal of Viral Hepatitis, 2007
- Regulating regulatory T cellsBone Marrow Transplantation, 2006
- Regulatory T-cell compartmentalization and traffickingBlood, 2006
- Liver‐targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis†Hepatology, 2006
- Regulatory T cells and the liverHepatology, 2005
- CCL3/MIP‐1α is pro‐inflammatory in murine T cell‐mediated hepatitis by recruiting CCR1‐expressing CD4+ T cells to the liverEuropean Journal of Immunology, 2004